Navigation Links
World Leaders in Alternative Cancer Treatment Join Forces
Date:9/23/2013

CHULAVISTA , California, September 23, 2013 /PRNewswire/ --

Two of the world's best known alternative cancer treatment specialists have joined together to offer a combination of their treatments in an exciting new move.

Drs. Donato Perez and Ariel Perez are well respected in their own fields of integrative cancer treatment; IPTLD and Functional Oncology respectively. Until now each physician has worked independently of the other, leading their own team of cancer specialists with remarkable results. However, in this exciting new development, the two physicians have joined forces, to create a cancer treatment program with the potential to achieve even higher success rates.

Functional Oncology is a unique 5 step program that helps to repair a patient's health on a cellular level, optimizing cellular health and boosting the immune system before using natural therapies which weaken and destroy cancer cells. Lead by Dr. Ariel Perez, the long term survival rate for Functional Oncology is at least double that of conventional therapy for all types of cancer. The long term survival rate for Functional Oncology patients with lung cancer is 29% compared to 3% for conventional treatment.

Whilst cancer is caused by a wide range of independent events, Westernized lifestyles undoubtedly contribute to the increase in chronic disease. Aimed at eliminating the potentially harmful toxicity levels within the cells that make it possible for cancer cells to rapidly grow and weaken the immune system, the 5 step program not only helps patients to beat cancer, but helps them to remain in remission.

IPTLD, or Insulin Potentiated Targeted Low Dose Chemotherapy is a program that has been developed over the last 80 years, by Dr. Donato Perez, his father and grandfather before him. There are currently 451 IPTLD certified practitioners worldwide, all of whom have been trained and certified by Dr. Donato Perez himself. Whilst IPTLD is conducted all over the world, Dr. Donato Perez is currently the only certified IPTLD practitioner in Mexico.

The treatment uses insulin and natural medicine to help chemotherapy to target only cancerous cells, whilst magnifying the effect of chemotherapy. Coupled with chemo sensitivity tests to determine the types of drug that each individual's cancer will react to, IPTLD enables patients to experience the undeniable benefits of chemotherapy without poisoning or damaging healthy cells. This practice dramatically reduces the side effects and potentially fatal consequences of chemotherapy, whilst harnessing the cancer killing power of the drug.

Based at Hospital Angeles Tijuana, and part of Angeles Health, Mexico's largest network of private hospitals, Drs. Donato Perez and Ariel Perez will offer patients Functional Oncology, IPTLD or a combination of the two, after assessing each individual patient for their physical condition and stage and type of cancer.

Both treatment programs include detoxification, nutrition and immune support phases but by combining their cancer fighting skills Drs. Ariel Perez and Donato Perez believe that they will see even more spectacular results.

It is beyond doubt that the partnership of these two pioneers of cancer treatment will give patients every chance of survival. This unique collaborative approach could even change the face of cancer treatment in the future, helping the world to beat cancer.

Angeles Health International

Angeles Health is Mexico's largest private hospital network. The company is comprised of 23 state-of-the-art hospitals totaling more than 2,000 beds and 200 operating rooms. Five million patients are treated each year by 11,000 Angeles Health physicians.

http://www.angeleshealth.com 

Cancertreatmentmx.com

The cancertreatmentmx.com website has been produced by Angeles Health, part of Mexico's largest private hospital network that supports more international patients than any other hospital network in the world.

The functional oncology center, located at the Hospital Angeles Tijuana, is a full-service, state-of-the-art hospital. It is widely recognized as one of the leading hospitals in Baja California. It is the ideal 'home' for the Functional Oncology program, the only full service hospital in Mexico offering integrative medicine.

cancertreatmentmx.com

For further information, please contact:
Angeles Health International
Carlos Zavala
COO
Email: info@angeleshealth.com
Telephone: 1-866-668-9263
US Direct: (619)-621-2800



'/>"/>
SOURCE Angeles Health International
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Global Sedimentation and Centrifugation Market 2012 - 2016: Worldwide Industry Latest Market Share, Growth, Size, Trends, Strategy and Forecast Research Report
2. Novartis marks World CML Day with update on global research program to evaluate whether Ph+ CML patients can live treatment-free
3. Emergent Technologies Selected to Serve 50 of the World’s Most Innovative Companies
4. Green Dot Holdings LLC CEO, Mark Remmert, Joins Industry Thought Leaders to Discuss Holistic Sustainable Design at A Better World by Design Conference
5. Global Biopesticides Market 2012-2016: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report 2016
6. Winton Symposiums material world
7. Worldwide Marine Biotech Market 2016
8. Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2012-2016 Report Available Online by Researchmoz.us
9. Global Biomaterials Market 2012-2016: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report
10. American Museum of Agriculture Changes Name to Reflect Bayer CropScience’s Agriculture Tradition and World-Class Technology
11. GUARDaHEART to Host Exclusive Event focused on Targeting Heart Disease in Celebration of the World Heart Day Mission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... 22, 2016  Amgen (NASDAQ: AMGN ) ... QB3@953 life sciences incubator to accelerate the development ... laboratory space at QB3@953 was created to help high-potential ... for many early stage organizations - access to laboratory ... Amgen launched two "Amgen Golden Ticket" awards, providing each ...
(Date:6/22/2016)... DUBLIN , June 22, 2016 Research ... and Global Markets" report to their offering. ... $39.4 billion in 2014 from $29.3 billion in 2013. The market ... (CAGR) of 13.8% from 2015 to 2020, increasing from $50.6 billion ... and projected product forecasts during the forecast period (2015 to 2020) ...
Breaking Biology Technology:
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
Breaking Biology News(10 mins):